Model‐based assessments of CYP3A‐mediated drug‐drug interaction risk of milademetan.
| Autor: | Hong, Ying1 (AUTHOR) yhong@dsi.com, Ishizuka, Tomoko2 (AUTHOR), Watanabe, Akiko3 (AUTHOR), Tachibana, Masaya3 (AUTHOR), Lee, Mark1 (AUTHOR), Ishizuka, Hitoshi3 (AUTHOR), LaCreta, Frank1 (AUTHOR), Abutarif, Malaz1 (AUTHOR) |
|---|---|
| Zdroj: | CTS: Clinical & Translational Science. Nov2021, Vol. 14 Issue 6, p2220-2230. 11p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|